Oct 21, 4:31 PM ET
Wyndham reported third-quarter 2026 results on October 21, 2026. Net revenues rose 7% to $410 million, but net income fell 6% to $99 million and diluted EPS fell 2% to $1.33, reflecting lower adjusted EBITDA. The company raised its full-year 2026 adjusted diluted EPS outlook to $4.84-$4.92 and its adjusted EBITDA outlook to $740-$745 million, and its board approved a $400 million increase in the share repurchase authorization.
- Net revenues rose 7% to $410 million, while net income fell 6% to $99 million and diluted EPS fell 2% to $1.33 from $1.36.
- Full-year 2026 adjusted diluted EPS outlook raised to $4.84-$4.92 from $4.71-$4.83; adjusted EBITDA outlook raised to $740-$745 million from $735-$745 million.
- U.S. RevPAR rose 6% year-over-year, while China RevPAR declined 10%.
- Repurchased $91 million of shares in the quarter; board increased the repurchase authorization by $400 million.
Read the filing on SEC.gov ↗
Jul 22, 4:31 PM ET
Wyndham reported second-quarter 2026 net income of $102 million, up 17% from a year earlier, and raised its full-year 2026 adjusted diluted EPS and adjusted EBITDA outlook. Net revenues fell 6% to $375 million, and the company removed Revo-related revenue from its outlook because of that franchisee's insolvency.
- Net revenues fell 6% to $375 million from $397 million; net income rose 17% to $102 million from $87 million.
- Diluted EPS was $1.36 versus $1.13; adjusted diluted EPS was $1.48 versus $1.33, or about 3% higher on a comparable basis.
- Full-year 2026 adjusted diluted EPS outlook raised to $4.71-$4.83 from $4.62-$4.80; adjusted EBITDA outlook raised to $735-$745 million from $730-$745 million.
- Returned $86 million to shareholders in the quarter, including $54 million of share repurchases; net debt leverage was 3.5 times.
Read the filing on SEC.gov ↗
May 18, 6:36 AM ET
Wyndham CEO Geoff Ballotti told team members on May 18, 2026 that he is undergoing treatment for multiple myeloma and plans to keep working largely as normal, with less travel. Chief Accounting Officer Nicola Rossi will leave on July 31, 2026, and Controller Christopher Androski will become Chief Accounting Officer on that date. At the May 14 annual meeting, stockholders re-elected all nine directors and approved a stockholder proposal on written consent.
- Ballotti's May 18 message (Exhibit 99.1) says he was diagnosed last week and began treatment at Beth Israel/Dana-Farber in Boston
- Rossi continues as Chief Accounting Officer until July 31, 2026; Androski, 52, is Senior Vice President and Controller and will succeed him
- All nine director nominees were elected at the May 14, 2026 annual meeting; say-on-pay passed with 54,328,340 votes for and 9,548,555 against
- Stockholders approved the written-consent proposal with 40,181,784 votes for and 23,709,518 against
Read the filing on SEC.gov ↗
Apr 29, 4:31 PM ET
Wyndham reported first-quarter 2026 net revenues of $327 million, up 3% from $316 million, and diluted EPS of $0.80 versus $0.78, while net income was flat at $61 million. It updated its full-year outlook: net revenues were raised to $1.47-$1.50 billion and global RevPAR growth range was narrowed, but adjusted net income was lowered to $351-$365 million, and adjusted EBITDA and adjusted diluted EPS guidance were unchanged.
- Q1 2026 net revenues rose 3% to $327 million; adjusted diluted EPS rose 12% to $0.96, or about 3% lower on a comparable basis
- Full-year 2026 net revenues outlook raised to $1.47-$1.50 billion from $1.46-$1.49 billion
- Full-year adjusted net income outlook lowered to $351-$365 million from $354-$368 million; adjusted EBITDA ($730-$745 million) and adjusted diluted EPS ($4.62-$4.80) outlooks unchanged
- Net debt leverage ratio was 3.5 times at March 31, 2026; the company issued $650 million of 5.625% senior unsecured notes due 2033 in February 2026
Read the filing on SEC.gov ↗
Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.
